City

Baltimore (1)

Chicago (1)

Rochester (1)

Scottsdale (1)

Seattle (1)

Overall Status

Completed (2)

Terminated (1)

Withdrawn (1)

Phase

phase 1/phase 2 (3)

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (2)

Fred Hutchinson Cancer Center (1)

Mayo Clinic (1)

Collaborator

National Cancer Institute (NCI) (1)

Study Documents

Intervention Type

biological (3)

drug (3)

other (2)

genetic (1)

Funder Type

NIH (2)

Other (2)

Study Type

Interventional (4)

philadelphia chromosome positive adult precursor acute lymphoblastic leukemia

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial

Completed

Has Results

Acute Undifferentiated Leukemia
+13 more

allopurinol
+16 more

Chicago, Illinois

Cancer and Leukemia Group B

Apr 5, 2022

Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia

Terminated

Has Results

Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia
Recurrent Adult Acute Lymphoblastic Leukemia

entinostat
+9 more

Baltimore, Maryland

Johns Hopkins University

Jul 7, 2017

Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor

Completed

Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia
+6 more

allogeneic cytomegalovirus-specific cytotoxic T lymphocytes

Seattle, Washington

Fred Hutchinson Cancer Research Center/University of Washington

Feb 14, 2017

B-cell Adult Acute Lymphoblastic Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1

Withdrawn

B-cell Adult Acute Lymphoblastic Leukemia
+4 more

nilotinib
+10 more

Scottsdale, Arizona
+1 more

Oct 29, 2015